This protocol describes a study designed to compare a new sleeping pill, zolpidem with a currently available preparation called tempazepam with regard to """"""""morning after performance"""""""". This will be a multicenter study involving 15 centers and approximately 630 normal subjects, 42 of whom will be enrolled a the BWH. Subjects will be randomized to three treatment groups such that 3/7 will be in each drug group and 1/7 in placebo group.
Showing the most recent 10 out of 721 publications